A Phase I, Open-Label, Dose-Escalation Study to Evaluate

Project: Research project

Project Details

Description

A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
StatusFinished
Effective start/end date12/18/0712/31/09

Funding

  • BIOMARIN PHARMACEUTICAL, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.